These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Takao S, Takebayashi Y, Che X, Shinchi H, Natsugoe S, Miyadera K, Yamada Y, Akiyama S, Aikou T. Clin Cancer Res; 1998 Jul; 4(7):1619-24. PubMed ID: 9676835 [Abstract] [Full Text] [Related]
11. Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer. Yoshikawa T, Suzuki K, Kobayashi O, Sairenji M, Motohashi H, Tsuburaya A, Nakamura Y, Shimizu A, Yanoma S, Noguchi Y. Br J Cancer; 1999 Mar; 79(7-8):1145-50. PubMed ID: 10098749 [Abstract] [Full Text] [Related]
12. p53, bcl-2 and thymidine phosphorylase as predictive markers of chemotherapy in patients with advanced and recurrent gastric cancer. Kikuyama S, Inada T, Shimizu K, Miyakita M, Ogata Y. Anticancer Res; 2001 Mar; 21(3C):2149-53. PubMed ID: 11501839 [Abstract] [Full Text] [Related]
13. Correlation between spontaneous apoptosis and the expression of angiogenic factors in advanced gastric adenocarcinoma. Ikeguchi M, Cai J, Fukuda K, Oka S, Katano K, Tsujitani S, Maeta M, Kaibara N. J Exp Clin Cancer Res; 2001 Jun; 20(2):257-63. PubMed ID: 11484984 [Abstract] [Full Text] [Related]